Cellectar Biosciences, Inc. Operating Lease Right-of-Use Assets
Cellectar Biosciences, Inc. (CLRB) had Operating Lease Right-of-Use Assets of $1.43 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $1.43M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $1.48M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $360.67K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $380.84K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $1.43M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.48M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $360.67K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $380.84K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $400.25K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $418.92K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $436.87K 10-K · filed 2026-03-04 |
| 2024-09-30 | $454.17K 10-Q · filed 2024-11-18 |
| 2024-06-30 | $470.82K 10-Q · filed 2024-10-29 |
| 2024-03-31 | $486.85K 10-Q/A · filed 2024-10-29 |
| 2023-12-31 | $502.28K 10-K · filed 2025-03-13 |
| 2023-09-30 | $517.57K 10-K/A · filed 2024-10-29 |
| 2023-06-30 | $532.30K 10-K/A · filed 2024-10-29 |
| 2023-03-31 | $546.50K 10-K/A · filed 2024-10-29 |
| 2022-12-31 | $560.33K 10-K/A · filed 2024-10-29 |
| 2022-09-30 | $138.10K 10-K/A · filed 2024-10-29 |
| 2022-06-30 | $161.11K 10-K/A · filed 2024-10-29 |
| 2022-03-31 | $183.29K 10-K/A · filed 2024-10-29 |
| 2021-12-31 | $204.64K 10-K · filed 2023-03-09 |
| 2021-09-30 | $225.21K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $244.99K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $264.04K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $282.37K 10-K · filed 2022-03-21 |
| 2020-09-30 | $299.98K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $316.92K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $333.20K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $348.84K 10-K · filed 2021-03-02 |
| 2019-09-30 | $363.86K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $378.28K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $392.12K 10-Q · filed 2019-05-06 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |